摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-chloro-4-isocyanato-2-methylbenzene | 51488-20-1

中文名称
——
中文别名
——
英文名称
1-chloro-4-isocyanato-2-methylbenzene
英文别名
4-chloro-3-methylphenyl isocyanate
1-chloro-4-isocyanato-2-methylbenzene化学式
CAS
51488-20-1
化学式
C8H6ClNO
mdl
——
分子量
167.595
InChiKey
CXYBLHZWJJNVQE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    244℃
  • 密度:
    1.17
  • 闪点:
    92℃

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    29.4
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 危险等级:
    6.1

SDS

SDS:e0a7326c400c94c75ea963d1ec95baba
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Chloro-3-methylphenyl isocyanate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Chloro-3-methylphenyl isocyanate
CAS number: 51488-20-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6ClNO
Molecular weight: 167.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质:闪点为93℃。

用途:用作农药中间体。

生产方法:3-氯-4-甲基苯胺光气化而得到3--4-甲苯异氰酸酯。具体步骤是将3-氯-4-甲基苯胺溶解在甲苯(或氯苯)中,使其浓度控制在150-170g/L。在0℃以下的低温条件下,通入光气光气体积约为胺的2.5倍(摩尔比)。随后缓缓升温至70-80℃,反应1-2小时后继续加热到100-105℃进行赶气处理,即可得到3--4-甲苯异氰酸酯溶液。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-chloro-4-isocyanato-2-methylbenzene 作用下, 反应 12.0h, 生成 C8H8ClNO2
    参考文献:
    名称:
    银介导的芳基氨基甲酸和亚硝基芳烃对吩嗪的环化
    摘要:
    开发了芳基氨基甲酸和亚硝基芳烃之间的银介导环化,导致吩嗪产量中等至良好,具有复杂性和多样性。该过程进行了芳基氨基甲酸的连续邻位C H 官能化、插入亚硝基和脱羧环化。
    DOI:
    10.1016/j.tetlet.2021.153550
  • 作为产物:
    描述:
    光气4-氯-3-甲基苯胺三乙胺 作用下, 以 二氯甲烷甲苯 为溶剂, 反应 4.08h, 以90%的产率得到1-chloro-4-isocyanato-2-methylbenzene
    参考文献:
    名称:
    Phenotypic Optimization of Urea–Thiophene Carboxamides To Yield Potent, Well Tolerated, and Orally Active Protective Agents against Aminoglycoside-Induced Hearing Loss
    摘要:
    Hearing loss is a major public health concern with no pharmaceutical intervention for hearing protection or restoration. Using zebrafish neuromast hair cells, a robust model for mammalian auditory and vestibular hair cells, we identified a ureathiophene carboxamide, 1 (ORC-001), as protective against aminoglycoside antibiotic (AGA)-induced hair cell death. The 50% protection (HC50) concentration conferred by 1 is 3.2 mu M with protection against 200 mu M neomycin approaching 100%. Compound 1 was sufficiently safe and drug-like to validate otoprotection in an in vivo rat hearing loss model. We explored the structureactivity relationship (SAR) of this compound series to improve otoprotective potency, improve pharmacokinetic properties and eliminate off-target activity. We present the optimization of 1 to yield 90 (ORC-13661). Compound 90 protects mechanosensory hair cells with HC50 of 120 nM and demonstrates 100% protection in the zebrafish assay and superior physiochemical, pharmacokinetic, and toxicologic properties, as well as complete in vivo protection in rats.
    DOI:
    10.1021/acs.jmedchem.7b00932
点击查看最新优质反应信息

文献信息

  • Functionalities tuned enantioselectivity of phenylcarbamate cyclodextrin clicked chiral stationary phases in HPLC
    作者:Jian Tang、Yuzhou Lin、Bo Yang、Jie Zhou、Weihua Tang
    DOI:10.1002/chir.22732
    日期:2017.9
    phenylcarbamate cyclodextrin (CD) clicked chiral stationary phases (CSPs). A comparison study is herein reported for per(4‐chloro‐3‐methyl)phenylcarbamate and per(2‐chloro‐5‐methyl)phenylcarbamate β‐CD clicked CSPs (i.e., CCC4M3‐CSP and CCC2M5‐CSP). The enantioselectivity dependence on column temperature was studied in both normal‐phase and reversedphase mode high performance liquid chromatography
    混合的官能团和甲基官能团可以极大地调节苯基氨基甲酸环糊精(CD)咔哒手性固定相(CSP)的对映选择性。本文报道了对(4--3-甲基)苯基氨基甲酸酯和(2--5-甲基)苯基氨基甲酸酯β-CD裂解的CSP(即CCC4M3-CSP和CCC2M5-CSP)的比较研究。在正相和反相模式高效液相色谱(HPLC)中均研究了对映选择性对柱温的依赖性。热力学研究表明,CCC4M3-CSP与手性溶质之间可形成更强的分子间相互作用,以驱动手性分离。通过在HPLC中对17种模型外消旋物进行对映分离,进一步证明了CCC4M3-CSP的对映选择性更高。
  • [EN] ISOINDOLINONE COMPOUNDS<br/>[FR] COMPOSÉS D'ISO-INDOLINONE
    申请人:MONTE ROSA THERAPEUTICS
    公开号:WO2021069705A1
    公开(公告)日:2021-04-15
    Disclosed herein is a compound or pharmaceutically acceptable salts or stereoisomers thereof of of formula I wherein X1 is linear or branched C1-6 alkyl, C3-6 cycloalkyl, -C1-6 alkyl C3-6 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, C1-6 alkyl C6-10 aryl, C1-6 alkyl 5-10 membered heteroaryl, wherein X1 is unsubstituted or substituted with one or more of halogen, linear or branched C1-6 alkyl, linear or branched C1-6 heteroalkyl, CF3, CHF2, -O-CHF2, -O-(CH2)2-OMe, OCF3, C1-6 alkylamino, -CN, -N(H)C(O)-C1- 6alkyl, -OC(O)-C1-6alkyl, -OC(O)-C1-4alkylamino, -C(O)O-C1-6alkyl, -COOH, - CHO, -C1-6alkylC(O)OH, -C1-6alkylC(O)O-C1-6alkyl, NH2, C1-6 alkoxy or C1-6 alkylhydroxy; X2 is hydrogen, C6-10 aryl, 5-10 membered heteroaryl, -O-(5-10 membered heteroaryl), 4-8 membered heterocycloalkyl, C1-4 alkyl 4-8 membered heterocycloalkyl, -O-(4-8 membered heterocycloalkyl), -O-C1-4 alkyl-(4-8 membered heterocycloalkyl), -OC(O)-C1-4alkyl-4-8 membered heterocycloalkyl or C6 aryloxy, wherein X2 is unsubstituted or substituted with one or more of linear or branched C1-6 alkyl, NH2, NMe2 or 5-6 membered heterocycloalkyl; n is 0, 1 or 2.
    本公开涉及一种化合物或药用可接受盐或其立体异构体,其化学式为I,其中X1为直链或支链的C1-6烷基,C3-6环烷基,-C1-6烷基C3-6环烷基,C6-10芳基,5-10成员杂芳基,C1-6烷基C6-10芳基,C1-6烷基5-10成员杂芳基,其中X1未取代或取代为一个或多个卤素,直链或支链的C1-6烷基,直链或支链的C1-6杂烷基,CF3CHF2,-O- ,-O-(CH2)2-OMe,O ,C1-6烷基基,-CN,-N(H)C(O)-C1-6烷基,-OC(O)-C1-6烷基,-OC(O)-C1-4烷基基,-C(O)O-C1-6烷基,-COOH,-CHO,-C1-6烷基C(O)OH,-C1-6烷基C(O)O-C1-6烷基,NH2,C1-6烷氧基或C1-6烷基羟基;X2为氢,C6-10芳基,5-10成员杂芳基,-O-(5-10成员杂芳基),4-8成员杂环烷基,C1-4烷基4-8成员杂环烷基,-O-(4-8成员杂环烷基),-O-C1-4烷基-(4-8成员杂环烷基),-OC(O)-C1-4烷基-4-8成员杂环烷基或C6芳氧基,其中X2未取代或取代为一个或多个直链或支链的C1-6烷基,NH2,NMe2或5-6成员杂环烷基;n为0、1或2。
  • Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
    申请人:——
    公开号:US20040014756A1
    公开(公告)日:2004-01-22
    Compounds having the formula 1 are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    具有以下化学式的化合物对抑制蛋白酪氨酸激酶具有用处。本发明还公开了制备这些化合物的方法、含有这些化合物的组合物,以及使用这些化合物进行治疗的方法。
  • METHOD AND PROCESS FOR PREPARATION AND PRODUCTION OF DEUTERATED OMEGA-DIPHENYLUREA
    申请人:Feng Weidong
    公开号:US20130035492A1
    公开(公告)日:2013-02-07
    Methods and processes for preparation and production of deuterated ω-diphenylurea are disclosed. Especially, a kind of deuterated ω-diphenylurea compounds which can inhibit phosphokinase and the preparation method of N-(4-chloro-3-(trifluoromethyl)phenye-N′-(4-(2-(N-d3-methylcarbamoyl)-4-pridinyloxy)phenyl)urea are disclosed. The said deuterated diphenylurea compounds can be used for treating or preventing tumors and relative diseases.
    揭示了制备和生产重氮化ω-二苯的方法和过程。特别是,揭示了一种可以抑制磷酸激酶的重氮化ω-二苯化合物以及N-(4--3-(三甲基)苯基-N′-(4-(2-(N-d3-甲基基甲酰)-4-吡啶氧基)苯基)尿素的制备方法。所述的重氮化二苯化合物可用于治疗或预防肿瘤及相关疾病。
  • PREPARATION METHOD OF FLUORO-SUBSTITUTED DEUTERATED DIPHENYLUREA
    申请人:Feng Weidong
    公开号:US20130060043A1
    公开(公告)日:2013-03-07
    A fluoro-substituted deuterated diphenylurea compound, especially 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-2-(N-(methyl-d3))picolinamide, preparing method and use for treating or preventing tumor and relative diseases thereof.
    一种代脱二苯化合物,特别是4-(4-(3-(4--3-(三甲基)苯基)基)-3-氟苯氧基)-2-(N-(甲基-d3))吡啶酰胺,其制备方法及用于治疗或预防肿瘤及相关疾病的用途。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫